Nobuyuki Yasuda,Fumitoshi Tago,Hiroko Baba,Tomohisa Nakano,Masahiko Mori
申请号：
US15791674
公开号：
US20180111988A1
申请日:
2017.10.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, and a method for treating rheumatoid arthritis using the pharmaceutical composition, wherein the pharmaceutical composition and the method bring about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis. The pharmaceutical composition in a method for treating rheumatoid arthritis comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient and is used such that at least 100 mg per dose of the anti-fractalkine antibody is subcutaneously administered to a human in need thereof.
